Member Info for appletree1

Isn't the temporary delay in the bigger rise here likely to be mostly due to the warrant overhang being burnt through? There are 200M warrant shares entered today as per last week's RNS. With about 150M shares sold so far today a sizeable chunk of the over-hang would have burnt through already giving a decent chance of a strong rise tomorrow or possibly Monday when the over-hang is gone.

Well at least the initial market reaction was positive.SP instantly recovered from the day low of 0.66 to blue at 0.83 USD just now on this buy-back announcement. Now at 0.75 USD. Still needs proper engagement from the BOD to turn this around properly though and will likely need SP consolidation if there isn't good progress by the Summer.

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repurchase program for up to $5 million of the Company’s common shares at any time. The term of the board authorization is until December 31, 2022. The repurchase program may be suspended or discontinued at any time and will be funded using the Company’s working capital.

Executive Chairman Gabriele Cerrone commented, “This announcement demonstrates our confidence in Tiziana’s business and the growth opportunities we see over the long term. We believe this is an attractive use of capital, and based on the strength of our balance sheet, we continue to see ample opportunity to invest and grow our business.”

No major selling showing today, only about 45k pounds in closely grouped round sells so probably just one or two individuals - and could be just to take advantage of opportunities that have arisen due to the markets being down overall today and a couple of stocks bouncing. Whatever the reason, I have added more to my holding.

Beesty, direct links to parallel markets are uncommon and don't apply to this stock. With parallel US stocks that are securitized ADRs of the UK LSE stock there is a direct link between the UK and the US stock prices and a common pooling of shares between them. Most parallel market stocks are, however, not linked by securitization and do not pool shares and are free to move independently of each other. The TSX and OTC listings are ordinary shares not securitized and therefore the relationship is a sentiment-based one rather than a direct link.In this case the US OTC and Canada TSX parallel market stocks influence UK and vice versa indirectly by sentiment (and to some extent by arbitrage), so the stock movements tend to very loosely mirror each other. IMHO serious/larger US investors will be as likely to buy LSE shares directly as buy US OTC shares and it is highly likely that some of the buying here in the afternoons is from US investors who prefer LSE stocks to OTC.

It certainly looks like the selling has dried up and the MMs are letting the SP here form a base at this level before the imminent news updates. The SP looks well supported and primed to go much higher, both from its own news and rolling forward with the expected firming of POG as US anti-inflationary measures (quarterly interest rate rises and withdrawal of QE) start to kick in. The stock will surely be on the radar of more and more investors. Just at the moment it is the Lithium mining, Oil and Gas stocks in my portfolio that are seeing the biggest rises while the Covid stocks and Crypto stocks are mostly in decline. I fully expect that it will be the gold miners turn to shine very shortly, and with its compelling fundamentals GCAT is well-positioned to attract increasing investment in the coming weeks. GCAT is accordingly amongst the largest holdings in my portfolio (and is replacing many of the Covid stocks in my portfolio that are now out of favour).

The 'off-radar before Covid' is one of several points that the de-rampers conveniently ignore. The low pre-Covid price on this stock was precisely because the medical growth stocks sector had been in down cycle, and this stock along with others was under-recognised and well below its fair value. The SP is resilient at this level precisely because it, and its considerable potential, is now well on the radar of a massively increased investor base who all know it was undervalued before Covid. Why do you think holders are reluctant to sell and the analysts still value the stock much higher than this even discounting the LFT?

Mumbo Jumbo is well known as a troll on other boards . Pity that posting history is not currently visible on this platform.

AG, I think the 2.87M sell was cancelled by the triple 0.958M trades all at the same time yesterday that show as negative trades. The cancelled 2.87M sell was presumably one holder recognizing that selling at 1.1p was a big mistake. Looking back over the week's trades, the selling after the Monday surge was constant but moderate and tapered off yesterday as the 1.1p low was reached. It seems to me that the volume of buys dipped after the Monday surge as the main market under-went the Fed-induced wobble. I suspect a few holders may have sold chunks to chase other stock bargains caused by that broader market dip.. Practically all of my growth stocks were down at the same time. As regards the 1M trade at 4:35 today it is a bit ambiguous to read - it might possibly be a buy, not a sell, since it is at mid-price and above the preceding sell prices though below the preceding buy prices. Either way, its nice to be heading up again and nice to see that new investors are coming to the stock. Roll on the news updates and fresh round of publicity for the stock.

Pobjoy Mint would quite possibly provide a tempting quote for a commission to make such coins, medallions or tokens from GCAT gold if GCAT like your idea but don't want to do it in-house. https://www.pobjoy.com/custom-minting/

So, I just bought a couple more small 500 pound top-ups at 1.14p and the bid recovers from 1p to 1.1p. Just shows that the MMs had no real reason to dip the bid in the first place.

It seems to be just the MMs gapping the bid down at the start of the day as usual. The offer price rarely dips by much. I suspect that we will see a good run up of the SP/ bid price when news arrives, but in the interim the MMs like to p... off holders by repeatedly gapping the bid.

Spot on Rockz regarding momentum trading. A lot of US pi's seem to be momentum traders at heart. The less liquid NASDAQ stocks do seem to see very large spikes and quite a few are much more extreme even than the ones we see on AIM. As a hilarious example (apart from the Reddit fun with Gamestop) look at the Kodak SP chart from Autumn 2020 when Trump was boasting about requisitioning Kodak to make basic sterilants. It has a saw-tooth series of daily 3,000% spikes from $7 up to $220 and back down again. So, yes there will have been some making errors with the TLSA v TSLA ticker that day but also a large crowd of momentum traders behind them exploiting the rise too.

See this news item, for example, which references the Robinhood buys of TLSA: https://markets.businessinsider.com/news/stocks/tesla-stock-tiziana-ticker-confusion-potentially-benefiting-biotech-company-mixup-2020-7 -
How many shares the Robinhoodies bought in error and then sold is IMHO not the most important aspect. The important aspect is the US public and shorters' perception. It is primarily because of the several articles like this one that the NASDAQ shorting surged way beyond normal levels and the SP collapsed in July 2020 and the stock continued to be heavily shorted for months afterwards.

I think GC was naive and possibly disingenuous to scapegoat AIM as the primary culprit for the 'poor SP performance' back then. The feverish trading causing the 3 pound spike within the opening hour of trading that Friday was almost certainly fueled in part by Robin Hood user illiteracy using their simplistic app and confusion over the stock split pricing that day. The lead up to the spike was primarily a product of and driven by genuine TILS news, publicity,the FEDs QE and Covid based market bullishness and strong sentiment/high investor expectations. The subsequent sell-off from the spike was partly the normal profit taking and partly selling by some Hoodies recognising their error. That initial selling was not the root of the SP collapse. The retrace was fundamentally massively exacerbated by shorters , with many shorting bears eg on Stocktwits crowing over the perceived stock ticker confusion after it was reported on by Bloomberg. It became a rallying cause to short TLSA whenever good news was issued in the UK. Every rise in the UK in the morning was met by US shorting in the afternoon. The level of shorting according to some sources frequently hit proportions akin to (illegal) naked shorting with half or more of daily volume being shorts. The TLSA ticker is in my view a bit of an albatross and even if it garners attention and leads to small brief gains from errors it attracted too much shorter attention then leading to falls that out-weighed gains. IMHO it would have been better if the ticker was changed at the time of the recent IPO, but I don't think it attracts as many shorters now as it did back then). irrespective of whether much confusion actually occurs in practice, the shorters definitely used it then as a reason to hammer the stock. I hold this stock in my portfolio because I believe strongly in the potential of the drugs and the scientific expertise. I don't think that the Nasdaq only move was good for the stock short-term (and I don't think AIM was inherently bad for it) but Nasdaq has the greater potential for serious ii investment in the stock rolling forward and will better support rises when the company gets closer to real progress over the coming months.

The CTDA approval to sell in the UK is the extra bureaucratic hurdle over and above CE mark that must yet be cleared to be able to sell in the UK. The 22 December RNS didn't make that clear but most people here know this. That is the reason for the parliamentary questions/ press headlines over the last few days.

Mr Mustard, see the page on this platform at lse.co.uk/aqse-share-prices/
They state that AQSE is eligible for SIPP.

AJ Bell actually promote Aquis for shareholding not just in ISA s but also in SIPPs on their website. Why don't HL ? Maybe I need to look at using them or ii as brokers. HL are convenient but do seem to be a bit limited in their scope of dealings. With HL I cannot even trade the ASX shares, non-Crest NASDAQ shares or US OTC shares that I seem to be accumulating from various LSE stock transfers and demergers.

Looks like another blatant tree-shake this morning. The SP has been dipped by the MMs on relatively low volume and despite BTC starting to firm up. Seems to be generously giving us another opportunity to buy more at half the 80p warrants strike price, so I've added more.

The Medusa website shows the Meduflow antigen test on the product page when the product page is accessed from the homepage, but shows the RSPT antibody test on the product page when accessed from the shop page. It looks like Medusa are making the switch to manufacturing and then selling Meduflow only. However, they might not yet have sufficient stock Meduflow to sell through the website but possibly have residual stock of the RSPT to clear and which is why it is still the only item on and linked through the shop page.